VRDN
USDViridian Therapeutics Inc. Common Stock
$22.550-0.170 (-0.748%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$22.720
High
$23.050
Low
$22.140
Volume
4.98M
Company Fundamentals
Market Cap
2.1B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
1.03M
Exchange
NCM
Currency
USD
52-Week Range
Low $9.9Current $22.550High $27.2
Related News
Analyst Upgrades
BTIG Reiterates Buy on Viridian Therapeutics, Maintains $61 Price Target
BTIG analyst Julian Harrison reiterates Viridian Therapeutics with a Buy and maintains $61 price target.
View more
BusinessWire
Viridian Therapeutics Announces Successful October Submission of Biologics License Application (BLA) to U.S. FDA for Veligrotug in Thyroid Eye Disease
- BLA for veligrotug successfully submitted to the U.S. Food and Drug Administration (FDA) in late October following recent consultation with the agency - - Veligrotug's Breakthrough Therapy Designation supports
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.